Aldeyra Therapeutics, Inc. (ALDX)
0.779
-0.01
(-1.44%)
USD |
NASDAQ |
Oct 15, 12:58
Aldeyra Therapeutics Market Cap : 46.99M for Oct. 15, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 47.68M |
| October 13, 2026 | 54.28M |
| October 12, 2026 | 54.64M |
| October 09, 2026 | 55.27M |
| October 08, 2026 | 57.17M |
| October 07, 2026 | 57.82M |
| October 06, 2026 | 55.25M |
| October 05, 2026 | 55.72M |
| October 02, 2026 | 70.58M |
| October 01, 2026 | 77.81M |
| September 30, 2026 | 74.20M |
| September 29, 2026 | 79.62M |
| September 28, 2026 | 69.97M |
| September 25, 2026 | 72.69M |
| September 24, 2026 | 73.59M |
| September 23, 2026 | 81.43M |
| September 22, 2026 | 84.15M |
| September 21, 2026 | 81.43M |
| September 18, 2026 | 82.04M |
| September 17, 2026 | 83.24M |
| September 16, 2026 | 82.64M |
| September 15, 2026 | 82.64M |
| September 14, 2026 | 88.07M |
| September 11, 2026 | 80.83M |
| September 10, 2026 | 88.07M |
| Date | Value |
|---|---|
| September 09, 2026 | 90.48M |
| September 08, 2026 | 92.89M |
| September 04, 2026 | 89.28M |
| September 03, 2026 | 89.28M |
| September 02, 2026 | 89.88M |
| September 01, 2026 | 89.88M |
| August 31, 2026 | 89.28M |
| August 28, 2026 | 89.58M |
| August 27, 2026 | 92.89M |
| August 26, 2026 | 94.10M |
| August 25, 2026 | 93.50M |
| August 24, 2026 | 91.69M |
| August 21, 2026 | 91.69M |
| August 20, 2026 | 90.48M |
| August 19, 2026 | 95.31M |
| August 18, 2026 | 93.50M |
| August 17, 2026 | 94.10M |
| August 14, 2026 | 94.10M |
| August 13, 2026 | 86.86M |
| August 12, 2026 | 91.69M |
| August 11, 2026 | 91.08M |
| August 10, 2026 | 91.08M |
| August 07, 2026 | 93.50M |
| August 06, 2026 | 95.91M |
| August 05, 2026 | 96.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.242B |
| Oncolytics Biotech, Inc. | 67.17M |
| Sangamo Therapeutics, Inc. | 57.96M |
| Sarepta Therapeutics, Inc. | 1.877B |
| Anixa Biosciences, Inc. | 93.90M |
Market Cap Related Metrics
| Price to Book Value | 1.240 |
| Price | 0.779 |
| Earnings Yield | -49.15% |